FOLLOW-ON HEALTH CARE COSTS IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS)

被引:0
|
作者
Berger, A. [1 ]
LaPensee, K. [2 ]
Oster, G. [1 ]
机构
[1] PAI, Brookline, MA USA
[2] Medicines Co, Parsippany, NJ USA
关键词
D O I
10.1016/j.jval.2013.08.1258
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A521 / A522
页数:2
相关论文
共 50 条
  • [31] EVALUATION OF CEREBROVASCULAR RISK BY ECOCOLORDOPPLER IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS)
    Zampi, G.
    Fini, F.
    Placanica, A.
    Illuminati, G.
    Torromeo, C.
    Barilla, F.
    Paravati, V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 236 - 236
  • [32] BENEFITS OF ICOSAPENT ETHYL IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME (ACS): REDUCE-IT ACS
    Steg, Philippe Gabriel
    Bhatt, Deepak L.
    Miller, Michael
    Brinton, Eliot A.
    Jacobson, Terry A.
    Ketchum, Steven
    Jiao, Lixia
    Pineda, Armando Lira
    Doyle, Ralph T.
    Tardif, J. R. Jean Claude
    Ballantyne, Christie M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1113 - 1113
  • [33] NEPHROPATHY BY CONTRAST IN ACUTE CORONARY SYNDROME (ACS)
    Macias-Guarasa, I.
    Fernandez-Zamora, M. D.
    Vera-Almazan, A.
    Gutierrez-Rodriguez, R.
    Rivera-Fernandez, R.
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [34] HYPERLIPIDAEMIA MANAGEMENT IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) AND STATIN INTOLERANCE
    Hossain, R.
    Rallison, C.
    ATHEROSCLEROSIS, 2018, 275 : E84 - E84
  • [35] ONE-YEAR HEALTH CARE COSTS FOR ACUTE CORONARY SYNDROME PATIENTS WITH DIFFERENT TREATMENT STRATEGIES DURING THE INITIAL HOSPITALIZATION
    Zhao, Z.
    Winget, M.
    VALUE IN HEALTH, 2009, 12 (07) : A327 - A327
  • [36] HEALTH ECONOMIC EVALUATION OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY PATIENTS (ACS) BASED ON THE PLATO STUDY FROM A SPANISH HEALTH CARE PERSPECTIVE
    Delgado-Ortega, L.
    Lopez-Sendon, J. L.
    Heras Fortuny, M.
    Alvarez Sanz, C.
    Nikolic, E.
    Mellstrom, C.
    Wallentin, L.
    VALUE IN HEALTH, 2011, 14 (07) : A372 - A372
  • [37] Impact of cardiac rehabilitation on 3 year outcomes amongst patients after acute coronary syndrome: (ACS) SNAPSHOT ACS follow-up study
    Redfern, J.
    Hyun, K.
    Brieger, D.
    Chew, D.
    French, J.
    Astiey, C.
    Gallagher, R.
    Ellis, C.
    Carr, B.
    Lefkovits, J.
    Nallaiah, K.
    Lintern, K.
    Neubeck, L.
    Briffa, T.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3108 - 3108
  • [38] Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study
    Chew, Derek P.
    French, John
    Briffa, Tom G.
    Hammett, Christopher J.
    Ellis, Christopher J.
    Ranasinghe, Isuru
    Aliprandi-Costa, Bernadette J.
    Astley, Carolyn M.
    Turnbull, Fiona M.
    Lefkovits, Jeffrey
    Redfern, Julie
    Carr, Bridie
    Gamble, Greg D.
    Lintern, Karen
    Howell, Tegwen E. J.
    Parker, Hella
    Tavella, Rosanna
    Bloomer, Stephen G.
    MEDICAL JOURNAL OF AUSTRALIA, 2013, 199 (03) : 185 - 191
  • [39] The measurement of anticardiolipin antibody in patients with acute coronary syndrome (ACS) and control group
    Salehi Omran, M. T.
    Mirzaei, F.
    Khososi Niaki, M. R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 152 - 152
  • [40] COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME (ACS) PATIENTS IN SPAIN
    Thurston, S.
    Webb, C.
    Rejas, J.
    Van Hout, B.
    VALUE IN HEALTH, 2010, 13 (03) : A165 - A166